Lithium salts in the management of the manic-depressive syndrome.
D000208:Acute Disease; D001714:Bipolar Disorder / Q000188:drug therapy* / Q000378:metabolism / Q000517:prevention & control; D002395:Catecholamines / Q000378:metabolism; D002746:Chlorpromazine / Q000627:therapeutic use; D003863:Depression / Q000188:drug therapy; D003919:Diabetes Insipidus / Q000139:chemically induced; D005947:Glucose / Q000378:metabolism; D006042:Goiter / Q000139:chemically induced; D006801:Humans; D007099:Imipramine / Q000627:therapeutic use; D008094:Lithium / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D010919:Placebos; D012559:Schizophrenia / Q000188:drug therapy
D002395:Catecholamines; D010919:Placebos; D008094:Lithium; D005947:Glucose; D007099:Imipramine; D002746:Chlorpromazine